Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Tax Provisions (2019 - 2025)

Pulmonx has reported Tax Provisions over the past 7 years, most recently at $128000.0 for Q3 2025.

  • Quarterly Tax Provisions fell 36.0% to $128000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $466000.0 through Sep 2025, down 38.44% year-over-year, with the annual reading at $500000.0 for FY2024, 12.43% down from the prior year.
  • Tax Provisions was $128000.0 for Q3 2025 at Pulmonx, down from $200000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $271000.0 in Q4 2023 and troughed at $38000.0 in Q4 2024.
  • The 5-year median for Tax Provisions is $112000.0 (2022), against an average of $128555.6.
  • Year-over-year, Tax Provisions soared 1000.0% in 2021 and then plummeted 85.98% in 2024.
  • A 5-year view of Tax Provisions shows it stood at $143000.0 in 2021, then surged by 76.92% to $253000.0 in 2022, then increased by 7.11% to $271000.0 in 2023, then plummeted by 85.98% to $38000.0 in 2024, then soared by 236.84% to $128000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Tax Provisions are $128000.0 (Q3 2025), $200000.0 (Q2 2025), and $100000.0 (Q1 2025).